Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |